ROIV
ROIVANT SCIENCES (ROIV)
NASDAQ
$39.69+$0.16 (+0.39%)
Price as of Nov 13, 2026 7:55 PM EST
  • $28.5B
    Market Cap
  • 94.83%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
FMR LLC
11.81%
85.6M
+4.6M (+5.32%)
Sep 30, 2026
BLACKROCK, INC.
8.54%
61.9M
+13.6M (+22.05%)
Sep 30, 2026
BLACKROCK FUNDING, INC. /DE
5.82%
42.2M
+195,472 (+0.46%)
Dec 31, 2024
VANGUARD GROUP INC
5.80%
42.1M
+3.3M (+7.74%)
Dec 31, 2025
MORGAN STANLEY
5.33%
38.6M
-4.0M (-10.33%)
Sep 30, 2026
BLACKROCK INC.
4.88%
35.4M
-817,249 (-2.31%)
Jun 30, 2024
QVT FINANCIAL LP
3.27%
23.7M
-1.4M (-6.06%)
Jun 30, 2026

Current Ownership Distribution

  • Institutions9.6B (85.92%)
  • Mutual Funds984.8M (8.77%)
  • Insiders596.9M (5.32%)
  • Other0 (0.00%)

Insider Transactions

  • 5.32% (596.9M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 12
    Number of InsiderSelling (last 12 months)
  • $24.2B
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Torti Frank
President and Vant Chair
Other
Nov 12, 2026
$13.3M
329,550
$40.36
12.4M
Gline Matthew
CEO
Other
Nov 12, 2026
$1.7M
41,179
$40.36
16.4M
Torti Frank
President and Vant Chair
Other
Nov 12, 2026
$2.6M
62,493
$41.13
12.3M
Gline Matthew
CEO
Other
Nov 12, 2026
$321,184.17
7,809
$41.13
16.4M
Torti Frank
President and Vant Chair
In Kind
Nov 12, 2026
$535,680.00
12,800
$41.85
12.3M
Gline Matthew
CEO
In Kind
Nov 12, 2026
$66,960.00
1,600
$41.85
16.4M
Pulik Richard
CFO
Exempt
Nov 11, 2026
$0.00
127,365
$0.00
487,635
Gline Matthew
CEO
Other
Nov 11, 2026
$1.3M
30,083
$41.63
16.5M
Torti Frank
President and Vant Chair
Other
Nov 11, 2026
$10.0M
240,755
$41.63
12.9M
Gline Matthew
CEO
Other
Nov 11, 2026
$794,199.05
18,905
$42.01
16.4M
Pulik Richard
CFO
Exempt
Nov 11, 2026
$490,355.25
127,365
$3.85
397,046
Torti Frank
President and Vant Chair
Other
Nov 11, 2026
$6.4M
151,293
$42.01
12.7M
Pulik Richard
CFO
Sell
Nov 11, 2026
$1.9M
45,195
$41.47
351,851
Pulik Richard
CFO
Sell
Nov 11, 2026
$3.5M
82,170
$42.03
269,681
Pulik Richard
CFO
Sell
Nov 11, 2026
$2.0M
47,635
$41.89
222,046
Gline Matthew
CEO
Other
Nov 10, 2026
$1.0M
25,841
$40.43
16.5M
Torti Frank
President and Vant Chair
Other
Nov 10, 2026
$7.0M
173,683
$40.43
13.3M
Gline Matthew
CEO
Other
Nov 10, 2026
$1.3M
32,490
$41.13
16.5M
Pulik Richard
CFO
Exempt
Nov 10, 2026
$481,250.00
125,000
$3.85
394,681
Torti Frank
President and Vant Chair
Other
Nov 10, 2026
$9.0M
218,369
$41.13
13.1M
Pulik Richard
CFO
Sell
Nov 10, 2026
$5.2M
125,000
$41.20
269,681
Pulik Richard
CFO
Exempt
Nov 10, 2026
$0.00
125,000
$0.00
615,000
Venker Eric
President & Immunovant CEO
Sell
Nov 03, 2026
$7.3M
200,000
$36.31
999,154
Venker Eric
President & Immunovant CEO
Sell
Oct 28, 2026
$7.3M
200,000
$36.59
1.2M
Epperly Melissa B,
Award
Oct 23, 2026
$0.00
513
$0.00
15,467
Epperly Melissa B,
In Kind
Oct 23, 2026
$4,232.84
116
$36.49
15,351
Sukhatme Mayukh
President & CIO
In Kind
Oct 16, 2026
$669,795.28
19,976
$33.53
18.6M
Gline Matthew
CEO
In Kind
Oct 16, 2026
$1.2M
34,638
$33.53
16.5M
Epperly Melissa B,
Exempt
Oct 01, 2026
$0.00
17,750
$0.00
151,416
Epperly Melissa B,
Exempt
Oct 01, 2026
$79,165.00
17,750
$4.46
32,704